The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial

Psycho-Oncology

Volumn 22, Issue 3, 2013, Pages 481-489

  Miller, S M ^a   Hudson, S V ^b   Egleston, B L ^a   Manne, S ^a,b   Buzaglo, J S ^a   Devarajan, K ^a   Fleisher, L ^a   Millard, J ^a   Solarino, N ^a   Trinastic, J ^a   Meropol, N J ^c  

^a FOX CHASE CANCER CENTER   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

cancer; clinical trials; decision making; oncology; preparation; self efficacy

Indexed keywords

ADULT; CANCER PATIENT; CLINICAL TRIAL (TOPIC); CONFLICT; CONSULTATION; FEMALE; HEALTH SURVEY; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PARTICIPATION; PRETEST POSTTEST DESIGN; REVIEW; SELF CONCEPT;

AGED; CLINICAL TRIALS AS TOPIC; CONFLICT (PSYCHOLOGY); DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; SELF EFFICACY;

EID: 84874720596     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3043     Document Type: Review

References (55)

1. Klabunde CN, Springer BC, Butler B, White MS, Atkins J,. Factors influencing enrollment in clinical trials for cancer treatment. South Med J 1999; 92 (12): 1189-1193.
2. Friedman MA, Cain DF,. National Cancer Institute sponsored cooperative clinical trials. Cancer 1990; 65 (10 Suppl): 2376-2382.
3. Go RS, Frisby KA, Lee JA, et al,. Clinical trial accrual among new cancer patients at a community-based cancer center. Cancer 2006; 106 (2): 426-433.
4. Wright JR, Whelan TJ, Schiff S, et al,. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 2004; 22 (21): 4312-4318.
5. Coalition of National Cancer Cooperative Groups, I. The summit series cancer clinical trials., 2000: (Available from: www.cancersummit.org).
6. Melisko ME, Hassin F, Metzroth L, et al,. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. Clin Breast Cancer 2005; 6 (1): 45-54.
7. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N,. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 2001; 19 (15): 3554-3561.
8. Lara PN, Jr, Higdon R, Lim N, et al,. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001; 19 (6): 1728-1733.
9. Paskett ED, Cooper MR, Stark N, et al,. Clinical trial enrollment of rural patients with cancer. Cancer Pract 2002; 10 (1): 28-35.
10. Townsley CA, Selby R, Siu LL,. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005; 23 (13): 3112-3124.
11. Mills, EJ, Seely, D, Rachlis, B, et al,. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 2006; 7 (2): 141-148.
12. Avis NE, Smith KW, Link CL, Hortobagyi GN, Rivera E,. Factors associated with participation in breast cancer treatment clinical trials. J Clin Oncol, 2006; 24 (12): 1860-1867.
13. Dilts DM, Sandler AB,. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol 2006; 24 (28): 4545-4552.
14. Pinto HA, McCaskill-Stevens W, Wolfe P, Marcus AC,. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative. Ann Epidemiol, 2000; 10 (8 Suppl): S78-S84.
15. Ellis PM, Butow PN, Tattersall MH,. Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet. Ann Oncol 2002; 13 (9): 1414-1423.
16. Jones JM, Nyhof-Young J, Moric J, Friedman, A, Wells, W, Catton, P,. Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ 2006; 21 (4): 237-242.
17. Meropol NJ, et al,. Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Compr Canc Netw 2007; 5 (8): 655-664.
18. Wright JR, Crooks D, Ellis PM, Mings D, Whelan TJ,. Factors that influence the recruitment of patients to Phase III studies in oncology. Cancer 2002; 95 (7): 1584-1591.
19. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E,. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003; 21 (5): 830-835.
20. Juraskova I, et al,. Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect 2008; 11 (3): 252-262.
21. Wallace K, et al,. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial. J Clin Oncol 2006; 24 (25): 4158-4162.
22. Juraskova I, et al,. Improving informed consent in clinical trials: successful piloting of a decision aid. J Clin Oncol 2007; 25 (11): 1443-1444 (author reply 1444).
23. Miller SM, American Psychological Association. Handbook of Cancer Control and Behavioral Science: A Resource for Researchers, Practitioners, and Policy Makers. 1st ed 2009, Washington, DC: American Psychological Association. xxiv, 652.
24. Meropol NJ, Weinfurt KP, Burnett CB, et al,. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 2003; 21 (13): 2589-2596.
25. O'Connor AM,. Validation of a decisional conflict scale. Med Dec Making, 1995; 15 (1): 25-30.
26. Butow P, et al,. Cancer consultation preparation package: changing patients but not physicians is not enough. J Clin Oncol 2004; 22 (21): 4401-4409.
27. Leighl NB, et al,. Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy. J Clin Oncol 2011; 29 (15): 2077-84.
28. Shepherd HL, Butow PN, Tattersall MH,. Factors which motivate cancer doctors to involve their patients in reaching treatment decisions. Patient Educ Couns 2011; 84 (2): 229-235.
29. O'Connor AM, et al,. A survey of the decision-making needs of Canadians faced with complex health decisions. Health Expect 2003; 6 (2): 97-109.
30. Hall MJ, et al,. Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing. Cancer Epidemiol Biomarkers Prev 2011; 20 (2): 249-254.
31. Manne SL, et al,. Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol 2010; 28 (8): 1366-1372.
32. Meropol NJ, et al,. PREACT: A web-based tool to provide preparatory education about clinical trials. ASCO Cancer Trial Accrual Symposium, 2010. (Available from: http://university.asco.org/dgtfiles/ClinTrials/Symposium/ 1PREACTMeropol.pdf).
33. Davis SW, Nealon EO, Stone JC,. Evaluation of the National Cancer Institute's clinical trials booklet. J Natl Cancer Inst Monogr 1993;(14): 139-145.
34. Stacey D, O'Connor AM, DeGrasse C, Verma S,. Development and evaluation of a breast cancer prevention decision aid for higher-risk women. Health Expect 2003; 6 (1): 3-18.
35. Cranney A, O'Connor AM, Jacobsen MJ, et al,. Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns 2002; 47 (3): 245-255.
36. Grant FC, Laupacis A, O'Connor AM, Rubens F, Robblee J,. Evaluation of a decision aid for patients considering autologous blood donation before open-heart surgery. CMAJ 2001; 164 (8): 1139-1144.
37. Bunn H, O'Connor A,. Validation of client decision-making instruments in the context of psychiatry. Can J Nurs Res 1996; 28 (3): 13-27.
38. Baron RM, Kenny DA,. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Person Soc Psychol 1986; 51 (6): 1173-1182.
39. Shrout PE, Bolger N,. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 2002; 7 (4): 422-445.
40. Curbow B, Fogarty LA, McDonnell K, Chill J, Scott LB,. Can a brief video intervention improve breast cancer clinical trial knowledge and beliefs? Soc Sci Med, 2004; 58 (1): 193-205.
41. Llewellyn-Thomas HA, Thiel EC, Sem FW, Woermke DE,. Presenting clinical trial information: a comparison methods. Patient Educ Couns, 1995; 25 (2): 97-107.
42. Meropol NJ, Buzaglo JS, Millard JL, et al,. Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Comp Cancer Netw 2007; 5 (8): 655-664.
43. Finn R,. Oncologist's role critical to clinical trial enrollment. J Natl Cancer Inst 2000; 92 (20): 1632-1634.
44. Guarino MJ, Masters GA, Schneider CJ, et al,. Barriers exist to patient participation in clinical trials. Proceeds Am Soc Clin Oncol 2005; 23 (16S):Abstract 6015.
45. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R,. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999; 52 (12): 1143-1156.
46. Goldman DP, Schoenbaum ML, Potosky AL, et al,. Measuring the incremental cost of clinical cancer research. J Clin Oncol 2001; 19 (1): 105-110.
47. Ho J, Pond GR, Newman C, et al,. Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital. BMC Cancer 2006; 6: 263.
48. Legge F, Eaton D, Molife R, et al,. Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer center. Gynecol Oncol 2007; 104 (3): 551-556.
49. Hudson SV, Momperousse D, Leventhal H,. Physician perspectives on cancer clinical trials and barriers to minority recruitment. Cancer Control 2005; 12 (Suppl 2): 93-96.
50. Winn RJ,. Obstacles to the accrual of patients to clinical trials in the community setting. Semin Oncol 1994; 21 (4 Suppl 7): 112-117.
51. Nguyen TT, Somkin CP, Ma Y, Fung LC, Nguyen T,. Participation of Asian-American women in cancer treatment research: a pilot study. J Natl Cancer Inst Monogr 2005;(35): 102-105.
52. Tu SP, Chen H, Chen A, Lim J, May S, Drescher C,. Clinical trials: understanding and perceptions of female Chinese-American cancer patients. Cancer 2005; 104 (12 Suppl): 2999-3005.
53. Jenkins V, Fallowfield L,. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer 2000; 82 (11): 1783-1788.
54. Madsen SM, Holm S, Riis P,. Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. J Med Ethics 2007; 33 (4): 234-240.
55. Lin JS, Finlay A, Tu A, Gany FM,. Understanding immigrant Chinese Americans' participation in cancer screening and clinical trials. J Community Health 2005; 30 (6): 451-466.